Cereal Beta-Glucan and Cardiovascular Disease Risk Reduction in Overweight and Obese populations: A Systematic Review and Meta-Analysis of Lipid, Blood Pressure, and Anthropometric Parameters

Obesity-related dyslipidemia and hypertension are the key drivers of global cardiovascular disease (CVD) mortality. Although the lipid-lowering capacity of beta-glucan has been demonstrated in the general population, evidence regarding its...